Eiger BioPharmaceuticals Overview

Eiger BioPharmaceuticals Gross Profit

Gross Profit analysis for EIGR.

Quarterly Gross Profit

$3.70M

↑ 57.46% YoY

As of Dec 31, 2023

Annual Gross Profit (TTM)

$15.13M

↑ 29.9% YoY

Trailing 12 months ending Dec 31, 2023

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin